{"id":"W2416001425","doi":"10.1080/13543784.2016.1195808","title":"Investigational targeted therapies for the treatment of testicular germ cell tumors","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Brentuximab vedotin; Clinical trial; Oncology; Internal medicine; Targeted therapy; Germ cell tumors; Sunitinib; Disease; Ifosfamide; Chemotherapy; Cancer; Lymphoma; Etoposide; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000680212,0.0005903178,0.001088887,0.002097096,0.0001827705,0.0007711768,0.0006883981,0.0008877009,0.005137483],"category_scores_gemma":[0.001001514,0.0001611941,0.0007411717,0.001838144,0.0003195805,0.0007701992,0.0005345109,0.001408119,0.001465129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004857268,"about_ca_system_score_gemma":0.0009838336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007152437,"about_ca_topic_score_gemma":0.001708442,"domain_scores_codex":[0.9997175,0.00006357415,0.00004646723,0.00003747953,0.0001120093,0.00002286398],"domain_scores_gemma":[0.9995288,0.0002339852,0.0001091013,0.00001069298,0.00009251096,0.00002491842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008197709,0.00005606401,0.0001418115,0.04128285,0.0001925864,0.0001789687,0.0000514281,0.0002555161,0.001041428,0.00192879,0.02446893,0.9303196],"study_design_scores_gemma":[0.00005939517,0.000140502,0.0009195318,0.02212918,0.0005047006,0.001532536,0.00007284283,0.0001087559,0.0005257233,0.00157655,0.9724116,0.00001884501],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005973054,0.9990859,0.00004546713,0.0001621831,0.000101051,0.000005174676,0.00001466047,0.000002785271,0.0005231194],"genre_scores_gemma":[0.0006076433,0.9987876,0.0001063072,0.0001561146,0.00008993043,0.000005860936,0.00002116149,7.685235e-7,0.0002246511],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005137483,"threshold_uncertainty_score":0.01718658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06552153533269944,"score_gpt":0.360707653935143,"score_spread":0.2951861186024436,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}